Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

Recent Finacing

Equity

Recent Raise

$50M

Recursion builds an AI- and automation-driven drug discovery platform combining high-throughput cellular imaging, deep learning, and bioinformatics to discover chemical entities, predict mechanisms, and enable partnered clinical programs.

Founded 2013
Utah, United States
501-1K
Publicly Traded
recursion.com

Highlights

Focus Areas

Artificial Intelligence (AI)
Biotechnology
Machine Learning
Pharmaceutical
Software
Therapeutics

Recent Investors

Felicis Ventures logo
Obvious Ventures logo
Epic Ventures logo
Lux Capital logo
Mubadala Investment Company logo
Advantage Capital logo
Baillie Gifford logo
Two Sigma Ventures logo
Intermountain Ventures logo
Data Collective logo
CRV logo
Square 1 Bank logo

Financials

$496.6M

Total Raised

7

Funding rounds

24

Investors


Team

Upgrade to view the team

See the team members at Recursion Pharmaceuticals.